Core Viewpoint - Haitong International has initiated coverage on H&H International Holdings with an "Outperform" rating and a target price of HKD 17, projecting net profits of RMB 415 million, RMB 641 million, and RMB 818 million for 2025 to 2027, representing year-on-year growth of 873.36%, 54.35%, and 27.50% respectively, with earnings per share of RMB 0.64, RMB 0.99, and RMB 1.27 [1] Group 1 - The company owns well-known brands such as Biostime, Swisse, and SolidGold, and has achieved a global presence through acquisitions [1] - H&H International has established R&D and production centers in Australia, France, and the United States [1] - Despite a slowdown in overall industry growth, the Adult Natural Health Nutrition and Care (ANC) business demonstrates resilience and growth potential, supporting the overall performance of the group [1]
大行评级丨海通国际：首予H&H国际控股“优于大市”评级及目标价17港元